Biogen (BIIB) Tops Q1 EPS by $1.40
Tweet
Share
E-mail
Get Alerts BIIB Hot Sheet
Price: $216.73 -0.19%
Revenue Growth %: +4.3%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
OCCI, VIVO, PMCB, More
Revenue Growth %: +4.3%
Financial Fact:
Diluted earnings per share attributable to Biogen Idec Inc.: 4.71
Today's EPS Names:
OCCI, VIVO, PMCB, More
Join SI Premium – FREE
Biogen (NASDAQ: BIIB) reported Q1 EPS of $9.14, $1.40 better than the analyst estimate of $7.74. Revenue for the quarter came in at $3.53 billion versus the consensus estimate of $3.41 billion.
For earnings history and earnings-related data on Biogen (BIIB) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Evercore cuts HPE rating amid 'tougher setup'
- Can the bull market survive surging oil prices & bond yields?
- Press Release: Sanofi and Cheplapharm to create new strategic partnership in mature medicines
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
